PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $427,328 | -27.3% | 162,482 | -2.5% | 0.00% | – |
| Q2 2023 | $588,020 | +0.9% | 166,578 | -11.7% | 0.00% | – |
| Q1 2023 | $582,771 | -63.5% | 188,599 | -50.0% | 0.00% | – |
| Q4 2022 | $1,595,548 | +270.2% | 377,198 | +107.6% | 0.00% | – |
| Q3 2022 | $431,000 | -16.8% | 181,703 | 0.0% | 0.00% | – |
| Q2 2022 | $518,000 | -71.9% | 181,703 | -71.6% | 0.00% | – |
| Q1 2022 | $1,842,000 | +4.8% | 639,629 | +10.6% | 0.00% | – |
| Q4 2021 | $1,757,000 | -60.7% | 578,090 | -9.4% | 0.00% | – |
| Q3 2021 | $4,470,000 | -68.2% | 637,720 | -58.3% | 0.00% | -100.0% |
| Q2 2021 | $14,041,000 | -37.8% | 1,529,520 | -34.2% | 0.00% | 0.0% |
| Q1 2021 | $22,581,000 | -1.8% | 2,323,155 | +3.6% | 0.00% | 0.0% |
| Q4 2020 | $23,003,000 | -19.2% | 2,242,037 | -20.5% | 0.00% | -50.0% |
| Q3 2020 | $28,460,000 | -19.1% | 2,820,641 | -16.4% | 0.00% | -33.3% |
| Q2 2020 | $35,189,000 | +17.8% | 3,373,857 | -4.7% | 0.00% | 0.0% |
| Q1 2020 | $29,874,000 | -2.7% | 3,539,620 | +0.9% | 0.00% | +50.0% |
| Q4 2019 | $30,688,000 | -3.9% | 3,507,152 | +18.3% | 0.00% | 0.0% |
| Q3 2019 | $31,925,000 | -47.3% | 2,965,656 | -37.7% | 0.00% | -60.0% |
| Q2 2019 | $60,523,000 | -11.9% | 4,761,831 | +169.0% | 0.01% | 0.0% |
| Q1 2019 | $68,676,000 | +18.0% | 1,770,445 | -38.1% | 0.01% | 0.0% |
| Q4 2018 | $58,193,000 | -37.2% | 2,859,610 | +41.5% | 0.01% | -28.6% |
| Q3 2018 | $92,643,000 | -20.5% | 2,020,462 | +2.5% | 0.01% | -30.0% |
| Q2 2018 | $116,604,000 | +15.0% | 1,971,243 | +32.3% | 0.01% | +11.1% |
| Q1 2018 | $101,379,000 | -13.6% | 1,489,768 | +25.4% | 0.01% | 0.0% |
| Q4 2017 | $117,394,000 | -23.9% | 1,187,559 | -7.8% | 0.01% | -30.8% |
| Q3 2017 | $154,162,000 | +45.1% | 1,287,329 | +5.9% | 0.01% | +44.4% |
| Q2 2017 | $106,225,000 | +90.4% | 1,215,354 | -19.0% | 0.01% | +80.0% |
| Q1 2017 | $55,792,000 | -6.6% | 1,499,747 | -22.9% | 0.01% | -16.7% |
| Q4 2016 | $59,746,000 | -2.4% | 1,946,098 | +113.1% | 0.01% | 0.0% |
| Q3 2016 | $61,228,000 | +94.7% | 913,183 | -13.5% | 0.01% | +100.0% |
| Q2 2016 | $31,441,000 | +0.8% | 1,055,380 | -0.7% | 0.00% | 0.0% |
| Q1 2016 | $31,200,000 | -47.8% | 1,062,291 | +39.4% | 0.00% | -57.1% |
| Q4 2015 | $59,731,000 | +14.4% | 761,829 | +10.0% | 0.01% | +16.7% |
| Q3 2015 | $52,192,000 | -28.0% | 692,406 | +11.5% | 0.01% | -25.0% |
| Q2 2015 | $72,523,000 | -40.7% | 621,197 | +19.9% | 0.01% | -38.5% |
| Q1 2015 | $122,367,000 | +30.1% | 518,268 | +4.3% | 0.01% | +44.4% |
| Q4 2014 | $94,090,000 | -14.2% | 497,090 | +8.2% | 0.01% | -25.0% |
| Q3 2014 | $109,616,000 | +155.0% | 459,468 | -29.5% | 0.01% | +140.0% |
| Q2 2014 | $42,987,000 | -22.3% | 651,349 | +22.6% | 0.01% | -16.7% |
| Q1 2014 | $55,329,000 | -0.4% | 531,298 | -0.9% | 0.01% | +50.0% |
| Q4 2013 | $55,527,000 | +195.1% | 536,339 | +53.0% | 0.00% | +100.0% |
| Q3 2013 | $18,815,000 | +34.3% | 350,646 | +11.1% | 0.00% | 0.0% |
| Q2 2013 | $14,006,000 | – | 315,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |